Initial results from the off‐label use of the SAPIEN S3 valve for percutaneous transcatheter pulmonary valve replacement: A multi‐institutional experience
Catheterization and Cardiovascular Interventions2018Vol. 93(3), pp. 455–463
Citations Over TimeTop 10% of 2018 papers
Sanjay Sinha, Jamil Aboulhosn, Jeremy D. Asnes, Martin L. Bocks, Evan M. Zahn, Bryan H. Goldstein, Jeffrey D. Zampi, William E. Hellenbrand, Morris Salem, Daniel S. Levi
Abstract
TPVR in patients with large diameter dysfunctional RVOTs can be effectively performed with the Sapien S3. All procedures were technically successful with no embolizations, no perivalvular leaks, and excellent short-term valve function. Tricuspid valve injury from implantation of an uncovered valve was a serious procedural complication.
Related Papers
- → Geometric mismatch of pulmonary and aortic anuli in children undergoing the Ross procedure: Implications for surgical management and autograft valve function(1998)39 cited
- → Transcatheter Aortic Valve-in-Valve Procedure in Patients with Bioprosthetic Structural Valve Deterioration(2017)35 cited
- → Early results of Pulsta® transcatheter heart valve in patients with enlarged right ventricular outflow tract and severe pulmonary regurgitation due to transannular patch(2022)9 cited
- → Current Experience with Percutaneous Pulmonary Valve Implantation(2006)41 cited
- → Patient-Specific Computer Simulation to Optimize Transcatheter Heart Valve Sizing and Positioning in Bicuspid Aortic Valve(2021)11 cited